Breaking News

Zealand Meets Development Milestone in Collaboration with Boehringer Ingelheim

Companies advanced therapeutic peptides stemming from the collaboration towards preclinical development

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Boehringer Ingelheim has selected a novel peptide therapeutic to be advanced into preclinical development under one of two ongoing collaboration agreements between itself and Zealand. This collaboration, initiated in July 2014, covers a novel therapeutic peptide project from Zealand’s preclinical portfolio with the aim of Zealand and Boehringer Ingelheim to join forces in the design and development of novel medicines for improved treatment of patients with cardio-metabolic diseases. The bi...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters